Post-earnings recap
Reported
Wed, May 5, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Soleno Therapeutics did not meet earnings expectations, which contributed to a slight decline in stock price. Investors may be concerned about the lack of revenue information and forward guidance. The stock's reaction suggests cautious sentiment among investors as the company continues to navigate its development efforts.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.11 | N/A | -175.00% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious outlook without offering specific future guidance. They emphasized their commitment to their development pipeline.
Management did not provide specific guidance for future performance.
The company is focused on ongoing development efforts.